Bill116th CongressFiled Sep 26, 2019Health
H.R. 4538
Closing Loopholes for Orphan Drugs Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Sep 26, 2019)
Closing Loopholes for Orphan Drugs Act
This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (i.e., drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.
What just happenedSep 27, 2019
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Welch, Peter [D-VT-At Large](D-VT)Sponsor
1 cosponsor1 R
1cosponsors1committees4actions4subjects
- Introduced in HouseSep 26, 2019
- Sep 27, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 26, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Sep 26, 2019IntroReferralIntro-H
Introduced in House
- Sep 26, 2019IntroReferral1000
Introduced in House